Connect with us

INDUSTRIAL HEMP

United Cannabis Corp (OTCMKTS:CNAB) Takes An Innovative Approach To The Cannabis Market

Published

on

United Cannabis Corp (OTCMKTS:CNAB) has taken an innovative approach to the cannabis market. Rather than simply offering over-the-counter products, the firm’s long-term objective is to advance its Prana offerings into a line of approved pharmaceutical medications that physicians can advise to their patients. The firm finalized a deal with the Caribbean Institute of Medical Research to move closer to accomplishing these objectives.

The details

United Cannabis reported the acquisition of a majority shares in Prana Therapeutics in July 2017. Under the deal terms, Prana will continue to run independently but Dr. Brent Reynolds has by now contributed his expertise in assisting the firm reach its objectives. The firm recently reported that it was issued US Patent giving it exclusive rights to its formulations dependent on compounds taken out from the cannabis crop.

Earnest Blackmon, the CEO, expressed that the patent showcases one of the cornerstones of its operations plan that eventually targets an FDA approval. This patent protects the application of suspending both cannabinoids and phytocannabinoids across numerous delivery mechanisms. Dr. Reynolds could also be vital in assisting the firm define its pathway through clinical studies.

In addition, EDP could be combined with Prana offerings to advance complementary treatments since both have distinct mechanisms of action that achieve the same objectives of reducing inflammation. Besides its clinical approach to cannabis, the company’s majority acquisition of Prana paves the way to non-cannabis pharmaceuticals and could help in pushing its own offerings through clinical and pre-clinical trials.

United Cannabis comes in the list of biotechnology firms dedicated to the advancement of phyto-therapeutic based goods supported by patented know-hows for the industrial, pharmaceutical and medical markets. The firm has long encouraged the application of cannabinoids for medicinal uses and is building a platform for developing targeted therapies to enhance the quality of life for patients across the world.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of MMJReporter.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Symbol        Alert        High        Gain

 

  VBIO          $0.67       $4.10      500%

  IMLFF        $0.11       $0.57      400%

  CMXC        $0.25       $0.45      80%

  REPCF       $0.54       $0.79      48%

 

Get Your Latest Winner Delivered to Your Inbox!

FREE

For The Next 48 Hours

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement